Company Filing History:
Years Active: 2025
Title: Michael Lawrence Doligalski: Innovator in Cancer Treatment
Introduction
Michael Lawrence Doligalski is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of oncology through his innovative work in developing therapeutic agents. His research focuses on polypeptides and their applications in treating diseases associated with specific targets.
Latest Patents
Doligalski holds a patent for "Nectin-4 binding miniproteins, conjugates and uses thereof." This patent includes polypeptides and conjugates, such as radionuclide conjugates, which are useful in compositions and methods for treating, diagnosing, monitoring, and imaging diseases related to the expression of Nectin-4.
Career Highlights
Doligalski is currently associated with Aktis Oncology, Inc., where he continues to advance his research in cancer treatment. His work is pivotal in developing new therapeutic strategies that can improve patient outcomes.
Collaborations
Some of his notable coworkers include William C Blackwell, III and Paul L Feldman. Their collaborative efforts contribute to the innovative environment at Aktis Oncology, Inc.
Conclusion
Michael Lawrence Doligalski's contributions to cancer research and treatment exemplify the impact of innovation in medicine. His work continues to pave the way for advancements in therapeutic approaches for challenging diseases.